Ustekinumab as induction and maintenance therapy in patients with inflammatory bowel disease and type II autoimmune pancreatitis: report of two cases.

Gaetano LauriFerdinando D'AmicoMariangela AlloccaDiego PalumboEmanuel Della-TorreFrancesco De CobelliClaudio DoglioniPaolo Giorgio ArcidiaconoGabriele CapursoSilvio Danese

Published in: Journal of Crohn's & colitis (2023)

Keyphrases

patients with inflammatory bowel disease
multiple sclerosis
drug induced
bone marrow
mesenchymal stem cells
cell therapy